Sensor and Electronic Health Records (EHR) Integration Pilot Study

CompletedOBSERVATIONAL
Enrollment

194

Participants

Timeline

Start Date

July 23, 2018

Primary Completion Date

September 27, 2019

Study Completion Date

September 27, 2019

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DEVICE

Mobile spirometer

Mobile spirometer will be used to measure FEV1 values weekly.

DEVICE

Device sensor

Sensors will be attached to rescue and maintenance inhalers to measure use of rescue medication and maintenance therapy.

DRUG

Salbutamol

Salbutamol MDI will be given as a rescue medication to be used on an as needed basis in this study.

DEVICE

Activity monitor

Subjects will be required to wear activity monitors daily to record their physical activity.

OTHER

electronic diary card

Electronic diary card will be completed daily by subjects in COPD cohort.

OTHER

CAT

Subjects will be required to complete CAT monthly.

OTHER

ACT

Subjects will be required to complete ACT monthly.

Trial Locations (1)

17822

GSK Investigational Site, Danville

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Geisinger HealthPlan

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY